IGC Pharma (IGC) Intangibles (2011 - 2026)
IGC Pharma (IGC) posted quarterly Intangibles of $427000.0 for Q1 2026, down 76.94% year-over-year from $1.9 million in Q1 2025, and down 3.17% quarter-over-quarter from $441000.0 in Q4 2025.
IGC Pharma (IGC) Intangibles (2011 - 2026) Analysis & Trends
IGC Pharma (IGC) has reported Intangibles for 16 consecutive years, with $427000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Intangibles fell 76.94% year-over-year to $427000.0; the TTM figure through Mar 2026 stood at $427000.0 (down 76.94% YoY), while the FY2026 annual figure was $427000.0, down 76.94% from the prior year.
- Intangibles declined to $427000.0 in Q1 2026 per IGC's latest filing, from $441000.0 in the prior quarter.
- Across five years, Intangibles topped out at $4.9 million in Q3 2025 and bottomed at $427000.0 in Q1 2026.
- Historically, Intangibles has averaged $1.2 million across 5 years, with a median of $927000.0 in 2024.
- Annual changes were most pronounced in 2025 — Intangibles jumped 745.58% — and 2026, when it plunged 76.94%.
- IGC Pharma's Intangibles stood at $476000.0 in 2022, then surged by 148.32% to $1.2 million in 2023, then surged by 58.12% to $1.9 million in 2024, then plunged by 76.4% to $441000.0 in 2025, then slipped by 3.17% to $427000.0 in 2026.
- Business Quant data shows IGC's Intangibles at $427000.0 in Q1 2026, $441000.0 in Q4 2025, and $4.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 93.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | IGC Pharma | 27.20 Mn | 26.94 Mn | - | 5.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 427,000.00 |
| Dec 31, 2025 | 441,000.00 |
| Sep 30, 2025 | 4.88 Mn |
| Jun 30, 2025 | 1.65 Mn |
| Mar 31, 2025 | 1.85 Mn |
| Dec 31, 2024 | 1.87 Mn |
| Sep 30, 2024 | 577,000.00 |
| Jun 30, 2024 | 1.05 Mn |
| Mar 31, 2024 | 927,000.00 |
| Dec 31, 2023 | 1.18 Mn |
| Sep 30, 2023 | 561,000.00 |
| Jun 30, 2023 | 630,000.00 |
| Mar 31, 2023 | 1.17 Mn |
| Dec 31, 2022 | 476,000.00 |
| Sep 30, 2022 | 952,000.00 |
| Jun 30, 2022 | 444,000.00 |
| Mar 31, 2022 | 646,000.00 |
| Dec 31, 2021 | 274,000.00 |
| Sep 30, 2021 | 139,000.00 |
| Jun 30, 2021 | 405,000.00 |